Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Broad Spectrum of Coreceptor Usage and Rapid Disease Progression in HIV-1–Infected Individuals from Central African Republic
2003 StandoutNobel
Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers
1999
Innate immune sensing and its roots: the story of endotoxin
2003 StandoutNobel
Immune activation in HIV-infected African individuals
1998
Clinical and Biological Evolution of HIV-1 Seroconverters in Abidjan, Côte d'Ivoire, 1997–2000
2002 StandoutNobel
Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival
2000 Standout
Concurrent infections and HIV pathogenesis
2000
Comparative, Quantitative Study of Lymphoid and Non-Lymphoid Uptake of 60 nm Polystyrene Particles
1994
Non-Hodgkin lymphoma in Uganda: a case–control study
2000
Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors
1997
Prokaryotic Glycoproteins
2003
Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients
2000
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications
1994 Standout
Bacterial lipopolysaccharides—Themes and variations
1996
Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial
1999
The Bacterial Cell Envelope
2010 Standout
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Strong Amerind/White Sex Bias and a Possible Sephardic Contribution among the Founders of a Population in Northwest Colombia
2000 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
HIV infection in Haiti: natural history and disease progression
2000
Biological roles of glycans
2016 Standout
HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia
2006 StandoutNobel
Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency Virus
2002
The biochemistry and medical significance of the flavonoids
2002 Standout
Biosynthesis and Expression of Cell-Surface Polysaccharides in Gram-Negative Bacteria
1993
Flavonoids: a review of probable mechanisms of action and potential applications
2001 Standout
The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions
1997
Protective and Damaging Effects of Stress Mediators
1998 Standout
Acute respiratory distress syndrome
2019 Standout
Chemical Probes of UDP-Galactopyranose Mutase
2006
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Ethiopia: between Sub-Saharan Africa and Western Eurasia
2005
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Human Genetic Affinities for Y-Chromosome P49a,f/TaqI Haplotypes Show Strong Correspondence with Linguistics
1997
Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus
1990
Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5
2000
LPS/TLR4 signal transduction pathway
2008 Standout
HIV Infection, Antiretroviral Therapy, and CD4+Cell Count Distributions in African Populations
2006
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 Standout
Stress, Adaptation, and Disease: Allostasis and Allostatic Load
1998 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Structural variation in the O‐specific polysaccharides ofKlebsiella pneumoniaeserotype O1 and O8 lipopolysaccharide: evidence for clonal diversity inrfbgenes
1993
Rapidly Fatal Outcome of Bacteremic Klebsiella pneumoniae Pneumonia in Alcoholics
1995
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
The neurobiology of stress: from serendipity to clinical relevance11Published on the World Wide Web on 22 November 2000.
2000 Standout
Identification of an ATP‐binding cassette transport system required for translocation of lipopolysaccharide O‐antigen side‐chains across the cytoplasmic membrane of Klebsiella pneumoniae serotype O1
1994
A simulated annealing approach to define the genetic structure of populations
2002 Standout
Maternal mortality: who, when, where, and why
2006 Standout
A Role for Hyaluronan in Macrophage Accumulation and Collagen Deposition after Bleomycin-Induced Lung Injury
2000
The Genetic Legacy of Paleolithic Homo sapiens sapiens in Extant Europeans: A Y Chromosome Perspective
2000 StandoutScience
Structures of the O-antigens of Klebsiella serotypes 02 (2a,2e), 02 (2a,2e,2h), and 02 (2a,2f,2g), members of a family of related D-galactan O-antigens in Klebsiella spp
1995
Klebsiella pneumoniaeLipopolysaccharide O Typing: Revision of Prototype Strains and O-Group Distribution among Clinical Isolates from Different Sources and Countries
1999
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
2015
Roles of N-Linked Glycans in the Endoplasmic Reticulum
2004 Standout
O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections
1997
2015 Standout
Antiviral therapy for human immunodeficiency virus infections
1995
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Clonally diverse rfb gene clusters are involved in expression of a family of related D-galactan O antigens in Klebsiella species
1996
2003 Standout
Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes
2000
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
2003 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Population Structure and Eigenanalysis
2006 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
2009 StandoutNature
Role of Rfe and RfbF in the initiation of biosynthesis of D-galactan I, the lipopolysaccharide O antigen from Klebsiella pneumoniae serotype O1
1995
Strong Amerind/White Sex Bias and a Possible Sephardic Contribution among the Founders of a Population in Northwest Colombia
2000 Standout
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
1989
Plant Products as Antimicrobial Agents
1999 Standout
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
Selective Depletion of Liver and Splenic Macrophages Using Liposomes Encapsulating the Drug Dichloromethylene Diphosphonate: Effects on Antimicrobial Resistance
1991
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Distinctive genetic signatures in the Libyan Jews
2001
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia
1994 StandoutNobel
Functional Analysis of the Galactosyltransferases Required for Biosynthesis of d -Galactan I, a Component of the Lipopolysaccharide O1 Antigen of Klebsiella pneumoniae
2001
Lipopolysaccharide Endotoxins
2002 Standout
Plastic and Human Health: A Micro Issue?
2017 Standout
The Klebsiella pneumoniae O Antigen Contributes to Bacteremia and Lethality during Murine Pneumonia
2004
A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides
1993
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Structural analysis of the O-antigen side chain polysaccharides in the lipopolysaccharides of Klebsiella serotypes O2(2a), O2(2a,2b), and O2(2a,2c)
1992
Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxC
2009 StandoutNobel
Molecular cloning of the rfb region of Klebsiella pneumoniae serotype O1:K20: the rfb gene cluster is responsible for synthesis of the D-galactan I O polysaccharide
1992
Impact of Viral Factors on Very Early In Vivo Replication Profiles in Simian Immunodeficiency Virus SIVagm-Infected African Green Monkeys
2005 StandoutNobel
Works of P. Smets being referenced
Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte dʼIvoire
1997
Structure of the O-specific polysaccharide chain from Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharide
1991
Toxicity and activity of purified trichosanthin
1991
Inhibition of Production of Tumor Necrosis Factor by Monoclonal Antibodies to Lipopolysaccharides
1992
Separation by high-performance liquid chromatography of oligosaccharides obtained after mild acid hydrolysis of Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharides
1989
Protective Effects of Murine Monoclonal Antibodies in Experimental Septicemia: E. coli Antibodies Protect Against Different Serotypes of E. coli
1989
Structure of the O-specific polysaccharide chain of Klebsiella pneumoniae O1K2 (NCTC 5055) lipopolysaccharide. A complementary elucidation
1992
Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae
1990
Hyaluronic acid‐degrading enzymes in rat alveolar macrophages and in alveolar fluid: stimulation of enzyme activity after oral treatment with the immunomodulator RU 41740
1988
Y-chromosome-specific haplotype diversity in Ashkenazic and Sephardic Jews.
1993
Opposite effects of a glucocorticoid and an immunostimulating agent on prostaglandin production by two different cell types.
1985
Enhanced resistance of mice against influenza virus infection after local administration of glycoprotein extracts from Klebsiella pneumoniae
1985
Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol
1987
Origins of Falasha Jews studied by haplotypes of the Y chromosome.
1999
Purification of the lipopolysaccharide fraction from Klebsiella pneumoniae O1 K2 by high-performance liquid chromatography
1987
Intestinal absorption of RU 41740, an immunomodulating compound extracted from Klebsiella pneumoniae, across duodenal epithelium and Peyer's patches of the rabbit
1987